2007
DOI: 10.1371/journal.pone.0001046
|View full text |Cite
|
Sign up to set email alerts
|

Site-Directed Mutations in the C-Terminal Extension of Human αB-Crystallin Affect Chaperone Function and Block Amyloid Fibril Formation

Abstract: BackgroundAlzheimer's, Parkinson's and Creutzfeldt-Jakob disease are associated with inappropriate protein deposition and ordered amyloid fibril assembly. Molecular chaperones, including αB-crystallin, play a role in the prevention of protein deposition.Methodology/Principal FindingsA series of site-directed mutants of the human molecular chaperone, αB-crystallin, were constructed which focused on the flexible C-terminal extension of the protein. We investigated the structural role of this region as well as it… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
50
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
6
1
1

Relationship

3
5

Authors

Journals

citations
Cited by 42 publications
(54 citation statements)
references
References 68 publications
4
50
0
Order By: Relevance
“…Similarly, we found that a double mutation in the C-terminal hinge region of αB-crystallin (i.e. I159A/I161A αB-crystallin) had no effect on its chaperone activity against amorphously aggregating target proteins, but it significantly enhanced its ability to prevent fibril formation by the model proteins κ-casein and ccβ-Trp [106]. Thus, whilst all sHsps share structural features, such as a conserved α-crystallin domain, the differences between the proteins play an important role in their interaction with target proteins.…”
Section: Shsps and The Aβ Peptidesmentioning
confidence: 77%
See 1 more Smart Citation
“…Similarly, we found that a double mutation in the C-terminal hinge region of αB-crystallin (i.e. I159A/I161A αB-crystallin) had no effect on its chaperone activity against amorphously aggregating target proteins, but it significantly enhanced its ability to prevent fibril formation by the model proteins κ-casein and ccβ-Trp [106]. Thus, whilst all sHsps share structural features, such as a conserved α-crystallin domain, the differences between the proteins play an important role in their interaction with target proteins.…”
Section: Shsps and The Aβ Peptidesmentioning
confidence: 77%
“…Whether these differences are manifested through distinct target protein binding sites or binding modes remains to be determined. Interestingly, this raises the possibility that mutant forms of sHsps may be designed as more effective inhibitors of fibril formation compared to the wild-type protein and therefore may be an avenue for therapeutic potential in the future [106]. In addition, the variation in chaperone activity of sHsps may provide clues as to the different nature of the partially folded intermediate which are the precursor(s) to disordered (amorphous) versus ordered (amyloid fibril) forms of aggregation.…”
Section: Shsps and The Aβ Peptidesmentioning
confidence: 99%
“…In vitro, it is well known that C-terminal truncation within the exposed C-terminal extension decreases the solubility of both Ac and Bc [6]. Deamidation occurs extensively to Ac and to Bc with age in the human lens [155] and leads to potential destabilising structural changes due to the introduction of an additional negative charge from the resultant aspartic or glutamic acid sidechains [156].…”
Section: Other Post-translational Modificationsmentioning
confidence: 99%
“…Interestingly, the E164X mutant showed a red shift in the minimum indicating that the deletion of the second of the two glutamic acid residues in the REEK motif does introduce a detectable change in secondary structure. A recent study showed an R163X mutant with significantly altered secondary structure compared with the wild type (27). The frameshift mutation, 464delCT, introduced a small blue shift of the minimum to 208 nm and the appearance of a shoulder at ϳ223 nm, both of which are indicative of increased helicity.…”
Section: Expression and Purification Of The C-terminal Extensionmentioning
confidence: 99%
“…Stepwise removal of C-terminal sequences from ␣A-crystallin, including the REEK motif, not only reduced oligomerization, but also resulted in the sequential loss of chaperone activity (26), despite the fact that the IX(I/V) motif was retained in the mutants investigated. Mutations of lysine and glutamic acid residues in the C-terminal extension can improve chaperone activity against amyloid fibril formation providing a potential application of ␣B-crystallin in the treatment of amyloid-related diseases (27). In ␣B-crystallin, there has not been any systematic analysis of the role of the C-terminal extension and therefore no potential explanation of whether the three mutations (450delA, Q151X, and 464delCT) cause the various diseases via the loss of chaperone function or perhaps by a different mechanism.…”
mentioning
confidence: 99%